Gastroenteritis in Pediatric Population of Qatar

Last updated: March 21, 2024
Sponsor: Hamad Medical Corporation
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gastroenteritis

Treatment

Molecular method (PCR)

Clinical Study ID

NCT03046342
14-00045
  • Ages 3-14
  • All Genders

Study Summary

Comparison of clinical and laboratory diagnosis for cause of Gastroenteritis(GE) depending on the clinical manifestation.Identifying the sources of viral, bacterial and parasitic GE in Pediatric population of Qatar

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All acute gastroenteritis patients between 3 months to 14 years presenting to PECcenters with acute diarrhea+/- vomiting with or without fever

Exclusion

Exclusion Criteria:

  1. Cases of vomiting +/- fever only without diarrhea
  2. Suspicion of surgical abdomen
  3. Bile stained vomitus
  4. Mal-absorption diseases as cystic fibrosis, celiac disease or increased secretion asdisaccharides deficiency
  5. Cases of Inflammatory bowel disease
  6. Antibiotic associated diarrhea
  7. Patients with immune deficiency
  8. Patients with chronic diarrhea (>2 weeks of diarrhea)
  9. Patients receiving long term medication for any disease

Study Design

Total Participants: 3000
Treatment Group(s): 1
Primary Treatment: Molecular method (PCR)
Phase:
Study Start date:
March 10, 2015
Estimated Completion Date:
December 10, 2024

Study Description

Processing of stool samples by molecular method (PCR) for children with GE including complete data collection. Patients are followed up for 14 days

Connect with a study center

  • Hamad medical corporation

    Doha, 3050
    Qatar

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.